Multimodal AI for Predicting Response to Neoadjuvant Immunotherapy in Gastric Cancer (PRISM-GC) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Multimodal AI for Predicting Response to Neoadjuvant Immunotherapy in Gastric Cancer (PRISM-GC)	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric neoplasm, neoplasm, stomach disorder	Recruiting	Not stated	2026-05-15		NCT07401199

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Baoding Central Hospital	1
Hengshui People's Hospital	17
Qun Zhao	8
Shijiazhuang People's Hospital	9
The Fifth Affiliated Hospital of Anhui Medical University	1
Wuhan University Affiliated People's Hospital	1

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Baoding Central Hospital	Baoding	China	1
Cangzhou People's Hospital	Cangzhou	China	1
Hengshui People's Hospital	Hengshui	China	2
Renmin Hospital of Wuhan University	Wuhan	China	1
Shijiazhuang People's Hospital	Shijiazhuang	China	1
The Fifth Affiliated Hospital of Anhui Medical University	Fuyang	China	1
the Fourth Hospital of Hebei Medical University	Shijiazhuang	China	6
The Second Affiliated Hospital of Xingtai Medical College	Xingtai	China	1
Yichang Central Hospital	Yichang	China	1